TITLE

Profit in Loss

AUTHOR(S)
Wellner, Alison Stein
PUB. DATE
July 2000
SOURCE
American Demographics;Jul2000, Vol. 22 Issue 7, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the development of the XeniCare program offered to patients using the Roche Laboratories' Xenical prescription obesity drug.
ACCESSION #
3293938

 

Related Articles

  • GPs should join debate on potential risk versus reward of obesity drug. Castaneda, Reynald // New Zealand Doctor;10/8/2014, p14 

    The article focuses on the debate by general practitioners (GP) and clinicians in New Zealand on the risks and reward of the obesity drug phentermine.

  • FDA Approves Lorcaserin for Treatment of Obesity.  // International Cardiovascular Research Journal;2012, Vol. 6 Issue 2, p66 

    The article reports on the approval of lorcaserin by the U.S. Food and Drug Administration (FDA) for the treatment of obesity as of June 2012.

  • Obesity drug endorsed by NICE. Wise, Jacqui // BMJ: British Medical Journal (International Edition);03/17/2001, Vol. 322 Issue 7287, p637 

    Reports on the possible availability of the anti-obesity drug orlistat (Xenical) throughout England and Wales on the National Health Service. Decision made by the National Institute for Clinical Excellence (NICE); Guidelines for prescribing orlistat, as one part of the management of obesity;...

  • THE NEW PRESCRIPTIONS.  // Marie Claire (US Edition);Oct2012, Vol. 19 Issue 10, p270 

    The article offers a preview on the two diet medications approved by the U.S. Food and Drug Administration (FDA), the Belviq and the combined phentermine and topiramate drug called Qsymia and another drug, the Contrave, which is to be reviewed by the agency after it was rejected in 2011.

  • WEIGHT WATCHER. Springen, Karen // Newsweek;2/6/2006, Vol. 147 Issue 6, p70 

    This article discusses the pros and cons of taking the weight loss drug orlistat, a medication which is marketed by Roche and is sold under the name of Xenical. Orlistat is prescribed by doctors as a weight loss drug and is typically recommended only for those patients suffering from...

  • Options for treating obesity. Campbell, Ian // GP: General Practitioner;4/26/2002, p70 

    Focuses on the options for general practitioners in treating obesity. Effectiveness of anti-obesity drugs; Requirements for drug administration; Importance of setting realistic targets.

  • Long-Term Results of Drug Treatment for Obesity. SLAWSON, DAVID // American Family Physician;3/1/2014, Vol. 89 Issue 5, p389 

    The article presents answers to a question on whether weight loss medications are effective as long-term treatment for obesity.

  • 5 that work. Nachatelo, Melissa // Natural Health;May/Jun2001, Vol. 31 Issue 4, p70 

    Presents information about different natural diet supplements used in the management of obesity. Green tea; Ephedra; Chromium.

  • New experimental drug helps obese patients lose weight.  // New York Amsterdam News;02/25/99, Vol. 90 Issue 9, p14 

    Highlights the results of a study conducted at Baylor College of Medicine in Houston, Texas indicating the potency of orlistat to promote weight loss among obese patients. Need for the combination of moderate-calorie diet; Mechanism of the drug's action; Adverse reactions.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics